Meta-analysis of macrophage migration inhibitory factor (MIF) gene -173G/C polymorphism and inflammatory bowel disease (IBD) risk

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 6, 2015, Pages 9570-9574

  Yang, Jianfeng ^a   Li, Yanqi ^b   Zhang, Xiaofeng ^a  

^a HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b RENMIN UNIVERSITY OF CHINA   (China)

Author keywords

Inflammatory bowel disease; Macrophage migration inhibitory factor; Meta analysis

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; INFLAMMATORY BOWEL DISEASE; META ANALYSIS; PROTEIN EXPRESSION;

EID: 84938316581     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. [1] Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K. Inflammatory bowel disease in the South Asian pediatric popula­tion of British Columbia. Am J Gastroenterol 2007; 102: 1077-83.
2. [2] Adamali H, Armstrong ME, McLaughlin AM, Cooke G, McKone E, Costello CM, Gallagher CG, Leng L, Baugh JA, Fingerle-Rowson G, Bucala RJ, McLoughlin P, Donnelly SC. Macrophage migration inhibitory factor enzy­matic activity, lung inflammation, and cystic fi­brosis. Am J Respir Crit Care Med 2012; 186: 162-9.
3. [3] Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. MIF as a glucocorticoid-induced modulator of cyto­kine production. Nature 1995; 377: 68-71.
4. [4] Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R. An essential regulatory role for mac­rophage migration inhibitory factor in T-cell ac­tivation. Proc Natl Acad Sci U S A 1996; 93: 7849-54.
5. [5] de Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, Mizoguchi E, Metz CN, Alsahli M, ten Hove T, Keates AC, Lubetsky JB, Farrell RJ, Michetti P, van Deventer SJ, Lolis E, David JR, Bhan AK, Terhorst C. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001; 2: 1061-6.
6. [6] Murakami H, Akbar SM, Matsui H, Onji M. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 2001; 31: 337-43.
7. [7] Dambacher J, Staudinger T, Seiderer J, Sisic Z, Schnitzler F, Pfennig S, Hofbauer K, Konrad A, Tillack C, Otte JM, Diebold J, Göke B, Ochsenkühn T, Lohse P, Brand S. Macrophage migration inhibitory factor (MIF) -173G/C pro­moter polymorphism influences upper gastro­intestinal tract involvement and disease activ­ity in patients with Crohn’s disease. Inflamm Bowel Dis 2007; 13: 71-82.
8. [8] Fei BY, Lv HX, Yang JM, Ye ZY. Association of MIF-173 gene polymorphism with inflammato­ry bowel disease in Chinese Han population. Cytokine 2008; 41: 44-7.
9. [9] Nohara H, Okayama N, Inoue N, Koike Y, Fujimura K, Suehiro Y, Hamanaka Y, Higaki S, Yanai H, Yoshida T, Hibi T, Okita K, Hinoda Y. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 2004; 39: 242-6.
10. [10] Przybyłowska K, Mrowicki J, Sygut A, Narbutt P, Dziki Ł, Dziki A, Majsterek I. Contribution of the -173 G/C polymorphism of macrophage migra­tion inhibitory factor gene to the risk of inflam­matory bowel diseases. Pol Przegl Chir 2011; 83: 76-80.
11. [11] Oliver J, Márquez A, Gómez-Garcia M, Martinez A, Mendoza JL, Vilchez JR, López-Nevot MA, Piñero A, de la Concha EG, Nieto A, Urcelay E, Martín J. Association of the macrophage mi­gration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut 2007; 56: 150-1.
12. [12] Shiroeda H, Tahara T, Nakamura M, Shibata T, Nomura T, Yamada H, Hayashi R, Saito T, Yamada M, Fukuyama T, Otsuka T, Yano H, Ozaki K, Tsuchishima M, Tsutsumi M, Arisawa T. Association between functional promoter polymorphisms of macrophage migration in­hibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine 2010; 51: 173-7.
13. [13] Sivaram G, Tiwari SK, Bardia A, Anjum F, Vishnupriya S, Habeeb A, Khan AA. Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expres­sion levels in patients with ulcerative colitis. Hum Immunol 2012; 73: 201-5.
14. [14] Falvey JD, Bentley RW, Merriman TR, Hampton MB, Barclay ML, Gearry RB, Roberts RL. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel dis­ease: an association study in New Zealand Caucasians and meta-analysis. World J Gastroenterol 2013; 19: 6656-64.
15. [15] Mrowicki J, Przybylowska-Sygut K, Dziki L, Sygut A, Chojnacki J, Dziki A, Majsterek I. The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population. Mol Biol Rep 2014; 41: 4639-52.
16. [16] Murakami H, Akbar SM, Matsui H, Horiike N, Onji M. Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcer­ative colitis. Clin Exp Immunol 200; 128: 504-10.
17. [17] Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H, Ohshima T, Une Y, Todo S. Involvement of macrophage migration inhibi­tory factor (MIF) in the mechanism of tumor cell growth. Mol Med 1998; 4: 707-14.